← All organizations

Argos Therapeutics

For profitWebsite ↗

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Mar 1, 2014

Acquired by Genexine, Inc. on Feb 13, 2019

Timeline

1990s

Jun 1, 1997
Argos Therapeutics— Founded

2010s

Feb 13, 2019
Genexine, Inc.— Acquired By

Drugs by trial phase (6 distinct, 11 trials)

Phase 3 (1 own, 0 via acquisition)

autologous dendritic cells

Phase 2 (3 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

ags-009

Other trials (1 own, 0 via acquisition)

ags-006

Indications

Studied for

Recent trials (15)

NCT02042248CollaboratorPhase 1Mar 1, 2014
NCT01582672Lead sponsorPhase 3Nov 1, 2012
NCT01482949Lead sponsorPhase 2Sep 1, 2011
NCT01482949Study directorPhase 2Sep 1, 2011
NCT01069809Lead sponsorPhase 2Jul 1, 2010
NCT00960362Study directorPhase 1Jul 1, 2009
NCT00960362Lead sponsorPhase 1Jul 1, 2009
NCT00672191Lead sponsorPhase 2Feb 1, 2008
NCT00678119Study directorPhase 2Jan 1, 2008
NCT00678119Lead sponsorPhase 2Jan 1, 2008
NCT00664482Lead sponsorN/AMay 1, 2007
NCT00381212CollaboratorPhase 1/Phase 2Sep 1, 2006
NCT00272649Lead sponsorPhase 1/Phase 2Jan 1, 2006
NCT00272649Study chairPhase 1/Phase 2Jan 1, 2006
NCT00087984Lead sponsorPhase 1/Phase 2Jan 1, 2004

Details

Founded: Durham, NC, US Jun 1, 1997
Last known activity: Mar 1, 2014